Ionis Pharmaceuticals Inc banner

Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 74.17 USD -2% Market Closed
Market Cap: $12.3B

Wall St Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 101.71 USD with a low forecast of 46.46 USD and a high forecast of 136.5 USD.

Lowest Forecast
Price Target
46.46 USD
37% Downside
Average Forecast
Price Target
101.71 USD
37% Upside
Highest Forecast
Price Target
136.5 USD
84% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
FLEX
Flex Ltd
3% Upside
ARDX
Ardelyx Inc
163% Upside
MEDP
Medpace Holdings Inc
8% Upside
LFUS
Littelfuse Inc
1% Upside

Revenue
Forecast

19% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
19% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 25%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IONS's stock price target?
Price Target
101.71 USD

According to Wall Street analysts, the average 1-year price target for IONS is 101.71 USD with a low forecast of 46.46 USD and a high forecast of 136.5 USD.

What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
25%

Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 8 years is 25%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett